Почетна › Рак бешике › Тексас › Dallas
Kliničke studije za Рак бешике u gradu Dallas, TX
27 studija za Рак бешике traži učesnike na lokacijama u gradu Dallas i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Тражи се учесникФаза 2
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Тражи се учесникФаза 1
- Cancer Center Outpatient Building, Dallas
- The University of Texas Southwestern Medical Center, Dallas
- UT Southwestern Medical Center - West Campus Building, Dallas
- и још 2
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Тражи се учесникФаза 1
- University of Texas Southwestern, Dallas
- Texas Oncology, P.A, Dallas
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Тражи се учесникФаза 2
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Тражи се учесникФаза 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Тражи се учесникФаза 3
- Parkland Health and Hospital System, Dallas
- UT Southwestern Medical Center, Dallas
Measuring Surgical Recovery After Radical Cystectomy
Тражи се учесникОпсервациона студија
- University of Texas - Southwestern, Dallas
Enfortumab Vedotin and Stereotactic Radiation for Localized Bladder Cancer
Тражи се учесникФаза 1/2
- UT Southwestern Medical Center, Dallas
DESTINY-PANTUMOUR04
Тражи се учесникОпсервациона студија
- Research Site, Dallas
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Тражи се учесникОпсервациона студија
- UT Southwestern Medical Center, Dallas
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Тражи се учесникФаза 2
- Urology Clinics of North Texas, PLLC, Dallas
- UT Southwestern Medical Center, Dallas
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
Тражи се учесникОпсервациона студија
- University of Texas Southwestern Medical Center, Dallas
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Тражи се учесникФаза 2/3
- Research Site, Dallas
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Тражи се учесникФаза 1/2
- UT Southwestern Medical Center, Dallas
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Тражи се учесникФаза 2
- Baylor Scott & White Research Institute, Dallas
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Тражи се учесникФаза 2
- Baylor Scott and White Research Institute, Dallas
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Тражи се учесникФаза 3
- Research Site, Dallas
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Тражи се учесникФаза 1
- NEXT Dallas, Dallas
Predicting BCG Response
Тражи се учесникОпсервациона студија
- University of Texas Southwestern, Dallas
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Тражи се учесник
- UT Southwestern Medical Center, Dallas
Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
Тражи се учесникОпсервациона студија
- UT Southwestern Medical Center, Dallas
Bladder Cancer Screening Trial
Тражи се учесник
- University of Texas Southwestern Medical Center, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Oncology - Dallas, Dallas
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Тражи се учесникФаза 1
- Mary Crowley Cancer Research, Dallas
- Baylor University Medical Center, Dallas
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
Тражи се учесникОпсервациона студија
- UT Southwestern Medical Center at Dallas, Dallas
Blue Light Cystoscopy With Cysview® Registry
Тражи се учесникОпсервациона студија
- UT Southwestern, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Dallas
Studije za Рак бешике u drugim gradovima
- New York City, NY36 студија
- Nashville, TN31 студија
- Houston, TX31 студија
- Boston, MA26 студија
- Washington, DC26 студија
- Los Angeles, CA25 студија
- Baltimore, MD24 студија
- Philadelphia, PA23 студија
- Edison, NJ23 студија
- St. Louis, MO22 студија
- Chicago, IL21 студија
- Seattle, WA21 студија
Ostale studije u gradu Dallas
- Рак дојке54 студија
- Немалоклетни карцином плућа53 студија
- Метастатски карцином44 студија
- Затајење срца42 студија
- Рак (све врсте)40 студија
- Рак простате39 студија
- Колоректални карцином34 студија
- Гојазност33 студија
- Рак јајника31 студија
- Рак плућа26 студија
- Карцином ендометријума25 студија
- Рак бубрега (карцином бубрежних ћелија)24 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.